Ossiform is a brand that is committed to improving the lives of individuals with bone defects. They specialize in providing patient-specific, natural, and resorbable bone implants to enhance patient outcomes. Their goal is to reduce complications, improve functional and aesthetic outcomes, and facilitate faster recovery.

Ossiform constantly strives to redefine bone replacements through progressive research and close collaboration with physicians and industry partners. They take a patient-centric approach and prioritize innovation, quality, and progress in order to provide top-notch implant solutions that promote the natural formation of new bone. With a mission to offer 3D printed natural bone implants, Ossiform aims to minimize complications, enhance functional and aesthetic outcomes, and expedite recovery.

Their vision is to personalize all bone implants and foster the natural formation of new bone. Ossiform values human health and well-being above all else. Their commitment to quality ensures that they deliver high-quality bone implants that meet or exceed customer expectations while adhering to relevant quality standards and regulations.

Moreover, they strive to make high-quality bone replacements accessible and affordable to hospitals worldwide. Innovation is at the core of Ossiform's DNA. They constantly challenge the status quo and develop revolutionary technologies to provide better solutions for patients and healthcare providers.

Their success lies in effectively implementing these innovations in clinical settings and driving advancements in the field of bone replacement. Collaboration is key to Ossiform's approach. They actively build and sustain partnerships with industry leaders to continuously improve their products and push the boundaries of what is possible.

The history of Ossiform dates back to 2014 when the founders, driven by the need for clinically implementable bone solutions, developed a novel bio-ink that could be 3D printed into personalized and resorbable bone implants. They aimed to address real clinical problems faced by surgeons and provide effective solutions. Ossiform's flagship product, the P3D Bone, offers numerous advantages.

Its unique structure is designed to facilitate the natural formation of new bone, and the material and structure allow for effective remodeling into new vascularized bone. The P3D Bone is patient-specific, meaning it is designed with the individual patient's uniqueness in mind. It eliminates the need for bone harvesting and ill-fitting permanent implants, offering a resorbable material with structural support.

Looking ahead, Ossiform has exciting developments in the pipeline. They plan to launch the P3D Bone Void Filler in 2023, which is a 3D printed, resorbable bone with modifiable dimensions and lifelike architecture. In 2024, they anticipate launching the patient-specific and resorbable P3D Bone Implant, tailored to each patient based on their own CT/MRI scan data.

Contacting Ossiform is made easy through their website, where customers can reach out for inquiries, quotes, or general questions. They provide exceptional customer support and expertise in medical 3D printing. Overall, Ossiform is a brand dedicated to revolutionizing bone replacement solutions, improving patient outcomes, and enhancing the quality of life for individuals with bone defects